Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement

Por Horneff, Gerd, Fitter, Sigrid, Foeldvari, Ivan, Minden, Kirsten, Kuemmerle-Deschner, Jasmin, Tzaribacev, Nicolay, Thon, Angelika, Borte, Michael, Ganser, Gerd, Trauzeddel, Rolf, Huppertz, Hans-Iko
Publicado em 2012